Advanced Search

Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2016 February;68(1) > Minerva Urologica e Nefrologica 2016 February;68(1):14-9

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536

Frequency: Bi-Monthly

ISSN 0393-2249

Online ISSN 1827-1758

 

Minerva Urologica e Nefrologica 2016 February;68(1):14-9

UROLOGY 

    REVIEW

Focus on desmopressin and enuresis: a review of literature

Pietro FERRARA 1, Flaminia VENA 2, Maria C. BASILE 2, Francesca IANNIELLO 1, Antonio GATTO 1

1 Institute of Pediatrics, Sacro Cuore Catholic University, Rome, Italy; 2 Campus Bio-Medico University, Rome, Italy

Nocturnal enuresis (NE) is a common disorder in children. Choice of treatment depends on the frequency and severity of symptoms, the child’s age and motivation. Treatment options for NE are alarm, desmopressin and imipramine. In particular, the main desmopressin therapeutical effect is the antidiuretic activity. The different formulations of desmopressin are an injectable solution, an oral tablet formulation and the recent oral lyophilisate (MELT). MELT with its higher biodisponibility guarantees the same therapy response of other formulations with a lower doses and it represents the first line and safety treatment for the NE.

language: English


FULL TEXT  REPRINTS

top of page